Viagra Use Raises Skin Melanoma Risk
|
By HospiMedica International staff writers Posted on 17 Jun 2014 |
|
A new study cautions that men who used the erectile-function drug Viagra (sildenafil) had almost twice the risk of melanoma compared with men who never used the drug.
Researchers at Brigham and Women's Hospital, Harvard Medical School (Boston, MA, USA), Indiana University (Indianapolis, USA), and other institutions conducted a prospective cohort study that analyzed data from the Health Professionals Follow-up Study (HPFS), starting in 1986 with a total enrollment of 51,529 male health professionals aged 40 to 75. In the year 2000 follow-up, participants were questioned regarding sildenafil use for erectile dysfunction; those who reported cancers at baseline were excluded. A total of 25,848 men remained in the analysis.
During follow-up (through 2010), the researchers identified 142 melanoma, 580 squamous cell carcinoma (SCC), and 3,030 basal cell carcinoma (BCC) cases. Recent sildenafil use at baseline was significantly associated with an increased risk of subsequent melanoma. In contrast, no increased risk of SCC was associated. Moreover, erectile function itself was not associated with an altered risk of melanoma. The study was published in the June 2014 issue of JAMA Internal Medicine.
"Our study cannot prove cause and effect; a longer follow-up and more detailed assessment of the dose and frequency of sildenafil use at multiple times would be necessary for future studies,” concluded senior author Jiali Han, PhD, of the Indiana School of Public Health, and co-authors. “Nevertheless, our data provide epidemiological evidence on possible skin adverse effects of phosphodiesterase 5A inhibitors and support continued investigation of this relationship.”
Recent studies have shown that activation of the oncogenic BRAF gene (a member of the Raf kinase family of growth signal transduction protein kinases) down-regulates phosphodiesterase 5A (PDE5A) levels; a similar result occurs following sildenafil use. The low PDE5A expression increases the invasiveness of melanoma cells, which could explain the adverse effect of sildenafil on melanoma risk. If the association proves to be a real relationship, then the effect on melanoma risk probably applies to all drugs in the PDE5-inhibitor class.
Related Links:
Brigham and Women's Hospital, Harvard Medical School
Indiana University
Researchers at Brigham and Women's Hospital, Harvard Medical School (Boston, MA, USA), Indiana University (Indianapolis, USA), and other institutions conducted a prospective cohort study that analyzed data from the Health Professionals Follow-up Study (HPFS), starting in 1986 with a total enrollment of 51,529 male health professionals aged 40 to 75. In the year 2000 follow-up, participants were questioned regarding sildenafil use for erectile dysfunction; those who reported cancers at baseline were excluded. A total of 25,848 men remained in the analysis.
During follow-up (through 2010), the researchers identified 142 melanoma, 580 squamous cell carcinoma (SCC), and 3,030 basal cell carcinoma (BCC) cases. Recent sildenafil use at baseline was significantly associated with an increased risk of subsequent melanoma. In contrast, no increased risk of SCC was associated. Moreover, erectile function itself was not associated with an altered risk of melanoma. The study was published in the June 2014 issue of JAMA Internal Medicine.
"Our study cannot prove cause and effect; a longer follow-up and more detailed assessment of the dose and frequency of sildenafil use at multiple times would be necessary for future studies,” concluded senior author Jiali Han, PhD, of the Indiana School of Public Health, and co-authors. “Nevertheless, our data provide epidemiological evidence on possible skin adverse effects of phosphodiesterase 5A inhibitors and support continued investigation of this relationship.”
Recent studies have shown that activation of the oncogenic BRAF gene (a member of the Raf kinase family of growth signal transduction protein kinases) down-regulates phosphodiesterase 5A (PDE5A) levels; a similar result occurs following sildenafil use. The low PDE5A expression increases the invasiveness of melanoma cells, which could explain the adverse effect of sildenafil on melanoma risk. If the association proves to be a real relationship, then the effect on melanoma risk probably applies to all drugs in the PDE5-inhibitor class.
Related Links:
Brigham and Women's Hospital, Harvard Medical School
Indiana University
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Baby Warmer
THERMOCARE Convenience
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
Channels
Artificial Intelligence
view channel
AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation
Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib... Read more
AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors
Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves.... Read more
Surgical Techniques
view channel
Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
Robot-assisted surgery (RAS) has gained significant popularity in recent years and is now extensively used across various surgical fields such as urology, gynecology, and cardiology. These surgeries, performed... Read more
AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
A revolutionary artificial intelligence (AI) technology that has proven faster and more accurate in diagnosing small bowel bleeding could transform gastrointestinal medicine. AnX Robotica (Plano, TX,... Read more
First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
It is estimated that over 6 million patients in the US and Europe are affected by ventricular arrhythmias, which include conditions such as ventricular tachycardia (VT) and premature ventricular contractions (PVCs).... Read more
Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
Soft robots often face challenges in being guided effectively because adding steering mechanisms typically reduces their flexibility by increasing rigidity. Now, a team of engineers has combined ancient... Read morePatient Care
view channel
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read more
Health IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Point of Care HIV Test Enables Early Infection Diagnosis for Infants
Early diagnosis and initiation of treatment are crucial for the survival of infants infected with HIV (human immunodeficiency virus). Without treatment, approximately 50% of infants who acquire HIV during... Read more
Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked.... Read more
New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and... Read moreBusiness
view channel
Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
Johnson & Johnson (New Brunswick, N.J., USA) and Shockwave Medical (Santa Clara, CA, USA) have entered into a definitive agreement under which Johnson & Johnson will acquire all of Shockwave’s... Read more
